![Nedjad Losic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nedjad Losic
Corporate Officer/Principal chez
CANTARGIA AB
Fortune : 14 166 $ au 31/05/2026
Profil
Nedjad Losic currently works at Cantargia AB, as Vice President-Biometrics from 2021.
Mr. Losic also formerly worked at Genmab A, as Director & Director-Biometrics from 2004 to 2013.
Mr. Losic received his graduate degree from the University of Lund.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CANTARGIA AB 0,02 % | 31/12/2024 | 60 000 ( 0,02 % ) | 14 166 $ | 31/05/2026 |
Postes actifs de Nedjad Losic
| Sociétés | Poste | Début |
|---|---|---|
| CANTARGIA AB | Corporate Officer/Principal | 01/09/2021 |
Anciens postes connus de Nedjad Losic
| Sociétés | Poste | Fin |
|---|---|---|
| GENMAB A/S | Directeur/Membre du Conseil | - |
Formation de Nedjad Losic
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
